These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17891581)

  • 1. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
    Mitchell SA; Balwinski KM
    Drug Dev Ind Pharm; 2007 Sep; 33(9):952-8. PubMed ID: 17891581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
    Mitchell SA; Balwinski KM
    J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of extended release mini-tablets using directly compressible grades of HPMC.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1690-7. PubMed ID: 23078551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.
    Mamani PL; Ruiz-Caro R; Veiga MD
    AAPS PharmSciTech; 2012 Dec; 13(4):1073-83. PubMed ID: 22907778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
    Shojaee S; Emami P; Mahmood A; Rowaiye Y; Dukulay A; Kaialy W; Cumming I; Nokhodchi A
    AAPS PharmSciTech; 2015 Dec; 16(6):1281-9. PubMed ID: 25771738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug/matrix former particle size.
    Heiman J; Tajarobi F; Gururajan B; Juppo A; Abrahmsén-Alami S
    AAPS PharmSciTech; 2015 Apr; 16(2):267-77. PubMed ID: 25273028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of source variation on drug release from HPMC tablets: linear regression modeling for prediction of drug release.
    Piriyaprasarth S; Sriamornsak P
    Int J Pharm; 2011 Jun; 411(1-2):36-42. PubMed ID: 21420475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD; Kuhelj V; Vrečer F; Baumgartner S
    Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation development of metoprolol succinate and hydrochlorothiazide compression coated tablets.
    Shah R; Parmar S; Patel H; Pandey S; Shah D
    Curr Drug Deliv; 2013 Dec; 10(6):631-44. PubMed ID: 23017092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.